The table below shows Bio-Rad Laboratories, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Revenue
$592.10M
$653.00M
$651.60M
$585.40M
$667.50M
$649.70M
Cost of revenue
$282.70M
$309.60M
$306.30M
$279.40M
-
$293.80M
Gross profit
$309.40M
$343.40M
$345.30M
$306.00M
$342.00M
$355.90M
R&D
$62.90M
$71.30M
$60.50M
$73.50M
-
$91.00M
BIO annual revenue (10-K history)
Bio-Rad Laboratories, Inc. reported annual revenue of $2.58B for fiscal year 2025. That is up 0.7% from $2.57B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $2.07B (FY 2016) to $2.58B. Figures come from the company's audited annual reports as filed with the SEC.
